Literature DB >> 34787738

Biomarker-Driven Prognostication in Merkel Cell Carcinoma: A Paradigm for Personalized Therapy.

Beth A Helmink1,2, George Ansstas3,2, Ryan C Fields4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34787738     DOI： 10.1245/s10434-021-11055-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  18 in total

1.  Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study.

Authors:  Kelly G Paulson; Christopher W Lewis; Mary W Redman; William T Simonson; Aaron Lisberg; Deborah Ritter; Chihiro Morishima; Kathleen Hutchinson; Lola Mudgistratova; Astrid Blom; Jayasri Iyer; Ata S Moshiri; Erica S Tarabadkar; Joseph J Carter; Shailender Bhatia; Masaoki Kawasumi; Denise A Galloway; Mark H Wener; Paul Nghiem
Journal:  Cancer       Date:  2016-12-07       Impact factor: 6.860

2.  High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome.

Authors:  Antoine Touzé; Emmanuelle Le Bidre; Hélène Laude; Maxime J J Fleury; Raphaël Cazal; Françoise Arnold; Agnès Carlotti; Eve Maubec; François Aubin; Marie-Françoise Avril; Flore Rozenberg; Mauro Tognon; Annabel Maruani; Serge Guyetant; Gérard Lorette; Pierre Coursaget
Journal:  J Clin Oncol       Date:  2011-03-21       Impact factor: 44.544

3.  Merkel cell polyomavirus infection occurs during early childhood and is transmitted between siblings.

Authors:  Claire Martel-Jantin; Vincent Pedergnana; Jérôme T J Nicol; Valérie Leblond; David-Alexandre Trégouët; Patricia Tortevoye; Sabine Plancoulaine; Pierre Coursaget; Antoine Touzé; Laurent Abel; Antoine Gessain
Journal:  J Clin Virol       Date:  2013-07-02       Impact factor: 3.168

4.  Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients.

Authors:  Kelly G Paulson; Joseph J Carter; Lisa G Johnson; Kevin W Cahill; Jayasri G Iyer; David Schrama; Juergen C Becker; Margaret M Madeleine; Paul Nghiem; Denise A Galloway
Journal:  Cancer Res       Date:  2010-10-19       Impact factor: 12.701

Review 5.  Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.

Authors:  Aric Colunga; Thomas Pulliam; Paul Nghiem
Journal:  Clin Cancer Res       Date:  2017-12-07       Impact factor: 12.531

6.  Clonal integration of a polyomavirus in human Merkel cell carcinoma.

Authors:  Huichen Feng; Masahiro Shuda; Yuan Chang; Patrick S Moore
Journal:  Science       Date:  2008-01-17       Impact factor: 47.728

7.  Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics.

Authors:  Kelly G Paulson; Song Youn Park; Natalie A Vandeven; Kristina Lachance; Hannah Thomas; Aude G Chapuis; Kelly L Harms; John A Thompson; Shailender Bhatia; Andreas Stang; Paul Nghiem
Journal:  J Am Acad Dermatol       Date:  2017-11-02       Impact factor: 11.527

8.  Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Christopher K Bichakjian; Thomas Olencki; Sumaira Z Aasi; Murad Alam; James S Andersen; Rachel Blitzblau; Glen M Bowen; Carlo M Contreras; Gregory A Daniels; Roy Decker; Jeffrey M Farma; Kris Fisher; Brian Gastman; Karthik Ghosh; Roy C Grekin; Kenneth Grossman; Alan L Ho; Karl D Lewis; Manisha Loss; Daniel D Lydiatt; Jane Messina; Kishwer S Nehal; Paul Nghiem; Igor Puzanov; Chrysalyne D Schmults; Ashok R Shaha; Valencia Thomas; Yaohui G Xu; John A Zic; Karin G Hoffmann; Anita M Engh
Journal:  J Natl Compr Canc Netw       Date:  2018-06       Impact factor: 12.693

Review 9.  Merkel Cell Polyomavirus and Merkel Cell Carcinoma.

Authors:  Valeria Pietropaolo; Carla Prezioso; Ugo Moens
Journal:  Cancers (Basel)       Date:  2020-07-03       Impact factor: 6.639

10.  Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System.

Authors:  Kelly L Harms; Mark A Healy; Paul Nghiem; Arthur J Sober; Timothy M Johnson; Christopher K Bichakjian; Sandra L Wong
Journal:  Ann Surg Oncol       Date:  2016-05-19       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.